Last edition
News about "Vimseltinib "
UK MHRA Approves Vimseltinib for Tenosynovial Giant Cell Tumours
UK MHRA approves Deciphera Pharma’s vimseltinib for adults with tenosynovial giant cell tumours affecting movement or where surgery is not an option.
Vimseltinib | 18/08/2026 | By News Bureau
ONO to Acquire Deciphera Pharma for USD 2.4 Billion
Deciphera Pharmaceuticals, Inc. has signed a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO).
Vimseltinib | 30/04/2024 | By Aishwarya | 1638
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy